Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...
A new randomized, double-blind, sham-controlled clinical trial reports that a non-invasive, home-based light therapy produced measurable improvements in objective cognitive performance in adults under ...
Concept Medical announces first patient enrollment in the STARS DAPT randomized clinical trial evaluating Abluminus™ NP ...
Any striking marketing claims in companies’ ads about the gut benefits of a popular probiotic may be full of, well, the same thing that has their target audience backed up. The study adds to a mixed ...
Patients undergoing cardiac surgery often receive red-cell transfusions, along with the associated risks and costs. Early intraoperative normovolemic hemodilution (i.e., acute normovolemic ...
RE104 is a proprietary, potential best-in-class, patented prodrug of 4-OH-DiPT, which is administered via a single subcutaneous injection. Reunion designed RE104 to deliver a short, acute psychoactive ...
Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...
Multi-Specialty CNS Research Center Strengthens Trial Execution and Patient Diversity in Alzheimer's Agitation Study - ...
Trachoma is the leading cause of infectious blindness in the world, with Ethiopia the most impacted country in Africa. In a clinical trial of more than 2,400 individuals, researchers led by Dr. John ...
People Science, a leader in decentralized clinical research, today announced the publication of a clinical study conducted with Verb Biotics in Nature Scientific Reports. The peer-reviewed trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results